
HPV DNA testing using Hybrid Capture 2 (Digene) was added to a program of liquid based (Thinprep, Cytyc) cervical cancer screening in a population of sexually active women aged from 20 to 62 years, without the history of uterine cervix pathology. 14.32% of 3832 women in this population were HPV positive. Positivity peaked in women aged 25-29 (19.4%) and gradually decreased, with 8% of positivity after 60 years. Positivity was independently related to parity, tobacco use and was correlated to cervical pathology. The rate of positivity in this population seems to preclude the use of HPV testing as a primary screening tool.
Adult, Vaginal Smears, Papillomavirus Infections, Smoking, Uterine Cervical Neoplasms, Cervix Uteri, Middle Aged, Sensitivity and Specificity, Parity, Risk Factors, DNA, Viral, Humans, Mass Screening, Female, France, Papillomaviridae
Adult, Vaginal Smears, Papillomavirus Infections, Smoking, Uterine Cervical Neoplasms, Cervix Uteri, Middle Aged, Sensitivity and Specificity, Parity, Risk Factors, DNA, Viral, Humans, Mass Screening, Female, France, Papillomaviridae
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 52 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
